| Literature DB >> 27078494 |
Yumei Guo1, Haijian Zhou2,3, Liyun Qin1, Zhizhao Pang1, Tian Qin2,3, Hongyu Ren2, Zhuo Pan1, Jikun Zhou1.
Abstract
This study aimed to assess the frequency of Klebsiella pneumoniae in food samples and to detect antibiotic resistance phenotypes, antimicrobial resistance genes and the molecular subtypes of the recovered isolates. A total of 998 food samples were collected, and 99 (9.9%) K. pneumoniae strains were isolated; the frequencies were 8.2% (4/49) in fresh raw seafood, 13.8% (26/188) in fresh raw chicken, 11.4% (34/297) in frozen raw food and 7.5% (35/464) in cooked food samples. Antimicrobial resistance was observed against 16 antimicrobials. The highest resistance rate was observed for ampicillin (92.3%), followed by tetracycline (31.3%), trimethoprim-sulfamethoxazole (18.2%), and chloramphenicol (10.1%). Two K. pneumoniae strains were identified as extended-spectrum β-lactamase (ESBL)-one strain had three beta-lactamases genes (blaSHV, blaCTX-M-1, and blaCTX-M-10) and one had only the blaSHV gene. Nineteen multidrug-resistant (MDR) strains were detected; the percentage of MDR strains in fresh raw chicken samples was significantly higher than in other sample types (P<0.05). Six of the 18 trimethoprim-sulfamethoxazole-resistant strains carried the folate pathway inhibitor gene (dhfr). Four isolates were screened by PCR for quinolone resistance genes; aac(6')-Ib-cr, qnrB, qnrA and qnrS were detected. In addition, gyrA gene mutations such as T247A (Ser83Ile), C248T (Ser83Phe), and A260C (Asp87Ala) and a parC C240T (Ser80Ile) mutation were identified. Five isolates were screened for aminoglycosides resistance genes; aacA4, aacC2, and aadA1 were detected. Pulsed-field gel electrophoresis-based subtyping identified 91 different patterns. Our results indicate that food, especially fresh raw chicken, is a reservoir of antimicrobial-resistant K. pneumoniae, and the potential health risks posed by such strains should not be underestimated. Our results demonstrated high prevalence, antibiotic resistance rate and genetic diversity of K. pneumoniae in food in China. Improved control and prevention strategies are urgently needed.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27078494 PMCID: PMC4831839 DOI: 10.1371/journal.pone.0153561
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers Used for PCR Amplification and Resistance Gene Sequencing.
| Gene | Primer Sequence (5’→3’) | Annealing Temp (°C) | Fragment (bp) | Reference | |
|---|---|---|---|---|---|
| Forward | Reverse | ||||
| TCAACATTTCCGTGTCG | CTGACAGTTACCAATGCTTA | 56 | 860 | [ | |
| ATGCGTTATATTCGCCTGTG | AGATAAATCACCACAATGCGC | 56 | 896 | [ | |
| CCGTTTCCGCTATTACAAACCG | GGCCCATGGTTAAAAAATCACTGC | 56 | 944 | [ | |
| ATGATGACTCACAGCATTCG | TCCCGACGGCTTTCCGCGTT | 56 | 833 | [ | |
| TTTGCCCGTGCGATTGG | CGACTTTCTGCCTTCTGCTCT | 50 | 368 | [ | |
| ATGGTGACAAAGAGAGTGCA | CCCTTCGGCGATGATTCTC | 50 | 870 | [ | |
| GCAGCACCAGTAAAGTGATGG | GCGATATCGTTGGTGGTACC | 56 | 524 | [ | |
| GAGAGTGCAACGGATGATG | TGCGGCTGGGTAAAATAG | 56 | 941 | [ | |
| GCTGACAGCCTCTTTCTCCAC | CCTCGACACGGRCAGGGTTA | 56 | 1082 | [ | |
| GGTCTGGCCCATGCAGGTGA | GGTCGAGCCGGTCTTGTTGA | 56 | 963 | [ | |
| AACTTTCACAGGTGTGCTGGGT | CCGTACGCATACTGGCTTTGC | 60 | 405 | [ | |
| ATTCGTATGCTGGATCTCGCCACC | CATGACCCAGTTCGCCATATCCTG | 50 | 396 | [ | |
| CACCACGAGAATAACC | GCCTTGAACTCGACCG | 50 | 1184 | [ | |
| GCCAATCGGGTTATTGGCAA | TGGGAAGAAGGCGTCACCCTC | 55 | 357 | [ | |
| ATTTCTCACGCCAGGATTTG | GATCGGCAAAGGTTAGGTCA | 55 | 627 | [ | |
| GATCGTGAAAGCCAGAAAGG | ACGATGCCTGGTAGTTGTCC | 55 | 469 | [ | |
| GGGTTGTACATTTATTGAATCG | CACCTACCCATTTATTTTCA | 55 | 307 | [ | |
| CGAGATCAATTTACGGGGAATA | AACAAGCTGAAGCGCCTG | 55 | 533 | [ | |
| ACGACATTCGTCAACTGCAA | TAAATTGGCACCCTGTAGGC | 55 | 417 | [ | |
| TTGCGATGCTCTATGAGTGGCTA | CTCGAATGCCTGGCGTGTTT | 55 | 482 | [ | |
| AACTGCTTGAGCCCGTAGAT | GTCTACGCCATGGACCTCAC | 55 | 596 | [ | |
| CGACCTTGCGAGAGAAAT | GTTCCATCAGCCCTTCAA | 55 | 626 | [ | |
| TACGTCATCATGGACAGG | GCCACTTCACGCAGGTTG | 55 | 460 | [ | |
| ATGACTGA CATGACCTTGCG | TTAGGCATCACTGCGTGTTCG | 55 | 540 | [ | |
| ATGGGCATCATTCGCACATGTAGG | TTAGGTGGCGGTACTTGGGTC | 55 | 873 | [ | |
| ATGCATACGCGGAAGGCAATAAC | CTAACCGGAAGGCTCGCAAG | 55 | 861 | [ | |
| ATGAGGGAAGCGGTGATCG | TTATTTGCCGACTACCTTGGTG | 55 | 792 | [ | |
| ATGGACACAACGCAGGTCGC | TTAGGCCGCATATCGCGACC | 55 | 534 | [ | |
| ATGGAATTGCCCAATATTATTC | TCAATTCAATTCATCAAGTTTTA | 55 | 781 | [ | |
| AGGTTGTTTCCATTTCTGAG | TCTCTTCATTCCCTTCTCC | 55 | 591 | [ | |
| CCCAAACAGACCGTAGAGGC | CTCAAACTCGGCGGGCAAGC | 55 | 585 | [ | |
| Integron I | GGCATCCAAGCACAAG | AAGCAGACTTGACCTGA | 55 | Variable | [ |
Antimicrobial Resistance Rates of 99 K. pneumoniae Isolates.
| Antimicrobial category | Antimicrobial | Range (μg/mL) | susceptible MIC | Intermediate MIC | Resistant MIC | Raw seafood isolates (n = 4) | Raw chicken isolates (n = 26) | Frozen raw food isolates (n = 34) | Cooked food isolates (n = 35) | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| R (%) | R (%) | R (%) | R (%) | R (%) | ||||||
| Amikacin | 8–32 | ≤8 | ≥32 | 0 | 0 | 0 | 0 | 0 | ||
| Gentamicin | 2–8 | ≤2 | 4 | >8 | 0 | 5 (19.2%) | 0 | 0 | 5 (5.1%) | |
| Imipenem | 1–8 | ≤8 | >8 | 0 | 0 | 0 | 0 | 0 | ||
| Meropenem | 1–8 | ≤8 | >8 | 0 | 0 | 0 | 0 | 0 | ||
| Cefazolin | 4–16 | ≤4 | 16 | >16 | 0 | 2 (7.7%) | 2 (5.9%) | 0 | 4 (4.0%) | |
| Ceftazidime | 1–16 | ≤1 | 2 | >16 | 0 | 0 | 0 | 0 | 0 | |
| Cefotaxime | 1–32 | ≤1 | 2 | >32 | 0 | 1 (3.8%) | 0 | 0 | 1 (1.0%) | |
| Cefepime | 2–16 | ≤2 | >16 | 0 | 1 (3.8%) | 0 | 0 | 1 (1.0%) | ||
| Aztreonam | 2–16 | ≤2 | 16 | >16 | 0 | 0 | 0 | 0 | 0 | |
| Ampicillin | 4–16 | ≤4–8 | 16 | >16 | 4 (100%) | 25 (96.2%) | 31 (91.2%) | 32 (91.4%) | 92 (92.9%) | |
| Piperacillin | 4–64 | ≤4–16 | 32 | >64 | 0 | 3 (11.5%) | 0 | 1 (2.9%) | 4 (4.0%) | |
| Amoxicillin-Clavulanate | 4/2-16/8 | ≤4/2-8/4 | 16/8 | >16/8 | 0 | 2 (7.7%) | 1 (2.9%) | 0 | 3 (3.0%) | |
| Ampicillin-Sulbactam | 4/2-16/8 | ≤4/2-8/4 | 16/8 | >16/8 | 0 | 4(21.4%) | 0 | 0 | 4 (4.0%) | |
| Piperacillin-Tazobactam | 4/4-64/4 | ≤4/4 | 8/4-16/4 | >64/4 | 0 | 0 | 0 | 0 | 0 | |
| Colistin | 0.5–2 | ≤0.5 | 1 | >2 | 0 | 0 | 0 | 0 | 0 | |
| Trimethoprim-Sulfamethoxazole | 0.5/9.5-2/38 | ≤0.5/9.5 | 1/19 | >2/38 | 0 | 13 (50.0%) | 2 (5.9%) | 3 (8.6%) | 18 (18.2%) | |
| Chloramphenicol | 4–16 | ≤4 | 8–16 | >16 | 0 | 8 (30.8%) | 1 (2.9%) | 1 (2.9%) | 10 (10.1%) | |
| Ciprofloxacin | 0.5–2 | ≤0.5–1 | 2 | >2 | 0 | 6 (23.1%) | 0 | 0 | 6 (5.9%) | |
| Levofloxacin | 1–8 | ≤1 | >8 | 0 | 3 (11.5%) | 0 | 0 | 3 (3.0%) | ||
| Moxifloxacin | 1–4 | ≤1 | 2–4 | >4 | 0 | 0 | 0 | 0 | 0 | |
| Tetracycline | 2–8 | ≤2 | >8 | 0 | 21 (80.8%) | 4 (11.8%) | 6 (17.1%) | 31 (31.3%) |
Characteristics of the 2 ESBL-Producing K. pneumoniae Isolates Detected in this Study.
| Strain ID | Antimicrobial resistance patterns | ESBL genes | MLST type |
|---|---|---|---|
| SJZ2013N33 | GEN-CZO-CAZ-CTX-FEP-ATM-AMP-PRL-AMC-SAM-SXT-C-TE | SHV, CTX-M-1, CTX-M-10 | 1651 |
| SJZ2013N75 | GEN-CZO-CAZ-CTX-FEP-ATM-AMP-PRL-AMC-SAM-SXT-C-TE | SHV | 1652 |
a Abbreviations of antimicrobials: AMI, amikacin; GEN, gentamicin; IPM, imipenem; MEM, meropenem; CZO, cefazolin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; AMP, ampicillin; PRL, piperacillin; AMC, amoxicillin-clavulanate; SAM, ampicillin-sulbactam; TZP, piperacillin-tazobactam; CL, colistin; SXT, trimethoprim-sulfamethoxazole; C, chloramphenicol; CIP, ciprofloxacin; LVX, levofloxacin; MXF, moxifloxacin; TE, tetracycline.
Characteristics of the Fluoroquinolone Resistance-Associated Genes in 4 Fluoroquinolone-Resistant or Intermediately Fluoroquinolone-Resistant K. pneumoniae Isolates Detected in this Study.
| Strain ID | Antimicrobial resistance patterns | Fluoroquinolone resistance-associated genes | |
|---|---|---|---|
| SJZ2013N75 | GEN-CZO-CAZ-CTX-FEP-ATM-AMP-PRL-AMC-SAM-SXT-C-TE | ||
| SJZ2013N28 | AMP-PRL-SXT-C-CIP-TE | ||
| SJZ2013N70 | GEN-AMP-SAM-SXT-C-CIP-LVX-TE | T247A (Ser83Ile) | |
| SJZ2013N7 | GEN-AMP-SAM-C-CIP-LVX-TE |
a SJZ2013N75 showed intermediate resistance to CIP.
b Abbreviations of antimicrobials: AMI, amikacin; GEN, gentamicin; IPM, imipenem; MEM, meropenem; CZO, cefazolin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; AMP, ampicillin; PRL, piperacillin; AMC, amoxicillin-clavulanate; SAM, ampicillin-sulbactam; TZP, piperacillin-tazobactam; CL, colistin; SXT, trimethoprim-sulfamethoxazole; C, chloramphenicol; CIP, ciprofloxacin; LVX, levofloxacin; MXF, moxifloxacin; TE, tetracycline.
Characteristics of the Aminoglycoside Resistance-Associated Genes in 5 Gentamicin-Resistant or Intermediately Gentamicin-Resistant K. pneumoniae Isolates Detected in this Study.
| Strain ID | Antimicrobial resistance patterns | aminoglycoside resistance-associated genes |
|---|---|---|
| SJZ2013N33 | ||
| SJZ2013N75 | ||
| SJZ2013N70 | ||
| SJZ2013N7 | ||
| SJZ2013N4 |
a Abbreviations of antimicrobials: AMI, amikacin; GEN, gentamicin; IPM, imipenem; MEM, meropenem; CZO, cefazolin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; AMP, ampicillin; PRL, piperacillin; AMC, amoxicillin-clavulanate; SAM, ampicillin-sulbactam; TZP, piperacillin-tazobactam; CL, colistin; SXT, trimethoprim-sulfamethoxazole; C, chloramphenicol; CIP, ciprofloxacin; LVX, levofloxacin; MXF, moxifloxacin; TE, tetracycline.
Fig 1Clustering of the 99 K. pneumoniae Isolates Based on PFGE Patterns.
The strain ID, isolation time, sample type, forms of drug-resistant, ESBL detection, antimicrobial resistance pattern, and PFGE pattern of each isolate are listed to the left of the patterns. In the column of “forms of drug-resistant”, “No” means not resistant to all drugs, “R” means non-susceptibility to at least 1 agent in one or two antimicrobial categories, “MDR” means non-susceptibility to at least 1 agent in 3 or more antimicrobial categories.